News

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.
A new clinic at Vanderbilt University Medical Center is a ray of light for patients like Louis Del Ray, who was diagnosed ...
Diagnosed with ALS at 33, Brooke Eby launched ALStogether, an online community offering connection, advice, and resources.
Thomas Mulligan explains how a brain implant enables ALS patients to control digital devices. Canada rescinds Digital Services Tax after Trump cuts off U.S. trade talks ...
The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).
Living close to cyanobacterial harmful algal blooms in US water bodies is associated with increased risk of mortality from ALS.
Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness as well as effective treatments.
Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...
An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...
Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...
New ALS codes are released all the time, so we’ll keep the list up to date as and when any new ones drop. Code Rewards; The1stSunSwordsman: 20 Technique Shards and 1 Pearl (NEW) ...
Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price.